Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Richard Barthel"'
Autor:
Dawn Mcguire, Richard Barthel, David M. Rosen, Yoshinari Kumagai, Meg Miller, Neil A. Segal, Samy Metyas
Publikováno v:
Poster Presentations.
Background In new draft guidance for OA drugs, the U.S. FDA notes the “well-recognized discordance” in clinical trials between structural imaging and patient benefit. In a randomized, double-blind, placebo-controlled trial, IA TPX-100 was associa
Publikováno v:
Postgraduate Medicine. 122:98-106
Nonsteroidal anti-inflammatory drugs (NSAIDs) are mainstays of the treatment of osteoarthritis (OA) but have dose- and age-related risks of gastrointestinal, cardiovascular, and renal adverse events (AEs). As a result, US and international guidelines
Publikováno v:
Postgraduate Medicine. 123:253-255
(2011). Response to Roth Letter to the Editor. Postgraduate Medicine: Vol. 123, No. 5, pp. 253-255.
Publikováno v:
Journal of Hand Therapy. 11:191-199
Objective. To analyze retrospectively a group of patients presenting to an outpatient hand rehabilitation clinic with complaints related to repetitive tasks of the upper extremity. Design. Retrospective case study reviewing 24 consecutive cases for p
Publikováno v:
Journal of medicinal chemistry. 55(17)
We prepared a number of N-phenethyltetrahydroisoquinolines structurally related to protoberberines. They were tested for activity against bacteria, fungi, and human leukemia HL-60 cells and also for inhibition of biosynthesis: ergosterol in yeasts an
Autor:
Roy D. Altman, H. Richard Barthel
Publikováno v:
Drugs. 71(10)
This review discusses the pharmacology, analgesic efficacy, safety and tolerability of topical NSAIDs, salicylates and capsaicin for the management of osteoarthritis (OA) pain. Topical therapies present a valuable therapeutic option for OA pain manag
Publikováno v:
Drugsaging. 28(1)
NSAIDs used for the treatment of osteoarthritis (OA) have dose-related risks for gastrointestinal, cardiovascular and renal adverse events (AEs), particularly in elderly patients. Topical NSAIDs reduce systemic NSAID exposure and may mitigate these r
Publikováno v:
Journal of AOAC INTERNATIONAL. 75:842-853
A study was conducted to validate the use of O- (2,3,4,5,6-pentafluorobenzyl) hydroxylamine hydrochloride (PFBOA) as an agent for the determination of formaldehyde, acetaldehyde, n-heptanal, n-decanal, and glyoxal, aldehydes commonly found as byprodu
Publikováno v:
Seminars in arthritis and rheumatism. 39(3)
Nonsteroidal anti-inflammatory drugs have dose-related adverse effects. Topical nonsteroidal anti-inflammatory drugs may offer local efficacy with low systemic drug levels. This study assessed the efficacy and safety of topical diclofenac sodium 1% g
Publikováno v:
Journal of clinical rheumatology : practical reports on rheumaticmusculoskeletal diseases. 8(5)
The authors describe a case of idiopathic nodular panniculitis (Weber-Christian disease) with recurrent febrile episodes resistant to glucocorticosteroids and methotrexate (MTX) in various combinations with hydroxychloroquine, azathioprine, cyclospor